Slide background

- Dr. Tao Guo

"We are committed to faster delivery of preclinical
candidate compounds with high success rate."

Tao Guo, Ph.D

Vice President of Medicinal Chemistry

Dr. Guo received his B.S. in chemistry from Peking University in 1984 and his Ph.D. in organic chemistry from Columbia University in 1990, followed by post-doctoral training in bioorganic chemistry at UC Berkeley from 1990 to 1992. 

From 1992 to 1995, he worked at Ariad Pharmaceuticals as Senior Research Scientist and from 1995 to 2008 he was employed at Pharmacopeia as Director of Chemistry where he led a team of over 30 researchers in drug discovery for potential treatments for Alzheimer’s disease, metabolic disease, inflammatory disease, schizophrenia, cancer, infertility, and graft-versus-host disease as well as the application of combinatorial chemistry and structure-based design to facilitate drug discovery.

He is an inventor of 10 preclinical candidate compounds with 2 advanced to Phase III and 1 advanced to Phase II. He is the recipient of 28 issued US patents and an author of over 50 peer-reviewed papers. He has served on the NIH Expert Review Panels, the Princeton ACS Fall Organic Chemistry Symposium Organizing Committee, the Editorial Board of ChemTracts – Organic Chemistry, and as the President and CEO of the CGP-Doering Foundation. Dr. Guo joined WuXi AppTec in December 2008 and he currently serves as the Vice President of Medicinal Chemistry, International  Discovery Service Unit. Dr. Guo received the Shanghai inaugural “Thousands Plan” award in 2011.